, using another person's login - "During the inspection, FDA investigators documented violations of Section 501 (a) (2)(B) of the Federal Food. Drug and Cosmetic Act (the Act) and deviations from the applicable
standards and requirements
of Title 21, Code of Federal Regulations, Parts 211 and 600-680, Subchapter F, (21 CFI? 211 and 600- 680)..."